(Q48439741)

11 February 2018

title

CSF myelin basic protein, IgG and IgM levels in 101 MS patients before and after treatment with high-dose intravenous methylprednisolone. (English)

1 reference

11 February 2018

author name string

Frequin ST

1

1 reference

11 February 2018

Barkhof F

2

1 reference

11 February 2018

Lamers KJ

3

1 reference

11 February 2018

Hommes OR

4

1 reference

11 February 2018

Borm GF

5

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 September 1992

1 reference

11 February 2018

Acta Neurologica Scandinavica

published in

1 reference

11 February 2018

volume

86

1 reference

11 February 2018

issue

3

1 reference

11 February 2018

page(s)

291-297

1 reference

11 February 2018

Steroid therapy in multiple sclerosis. Point of view

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.1992.TB05088.X

Quantitative MRI changes in gadolinium-DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.1992.TB05088.X

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.1992.TB05088.X

Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.1992.TB05088.X

Cerebrospinal myelin basic protein in multiple sclerosis. Identification of two groups of patients with acute exacerbation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.1992.TB05088.X

10.1111/J.1600-0404.1992.TB05088.X

21 January 2018

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

1384263

1 reference

11 February 2018